Fel d 1-derived T cell peptide therapy induces recruitment of CD4+ CD25+; CD4+ interferon-gamma+ T helper type 1 cells to sites of allergen-induced late-phase skin reactions in cat-allergic subjects.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples